JW Life Science Corp
234080
Company Profile
Business description
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.
Contact
28, Hanjin 1-gil
Songak-eup, Dangjin-si
Chungcheongnam-do
Seoul343-823
KORT: +82 413517600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
336
Stocks News & Analysis
stocks
The strange effect of the 30% minimum capital gains tax
How the proposed CGT floor creates unexpected outcomes across different incomes.
stocks
Major ASX miner reduces aluminium exposure
The Alcoa transaction unlocks value and sharpens ASX miners focus on base metals.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,004.70 | 38.80 | -0.43% |
| CAC 40 | 8,499.42 | 19.55 | 0.23% |
| DAX 40 | 25,643.49 | 174.40 | -0.68% |
| Dow JONES (US) | 53,055.91 | 155.84 | 0.29% |
| FTSE 100 | 10,683.99 | 32.22 | 0.30% |
| HKSE | 23,496.89 | 119.43 | -0.51% |
| NASDAQ | 26,121.16 | 288.49 | 1.12% |
| Nikkei 225 | 68,256.96 | 1,480.73 | -2.12% |
| NZX 50 Index | 13,762.79 | 0.31 | -0.00% |
| S&P 500 | 7,537.43 | 54.19 | 0.72% |
| S&P/ASX 200 | 8,803.90 | 35.50 | -0.40% |
| SSE Composite Index | 3,990.24 | 51.00 | -1.26% |